Cintia Piccina - Mar 18, 2024 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Chief Commercial Officer
Signature
/s/ Cintia Piccina
Stock symbol
ADAP
Transactions as of
Mar 18, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 05:00 PM
Previous filing
Jul 5, 2023
Next filing
Jun 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +5.09M $0.00 5.09M Mar 18, 2024 Ordinary Shares 5.09M $0.25 Direct F1, F2
transaction ADAP Option to purchase Ordinary Shares Award $0 +1.13M $0.00 1.13M Mar 18, 2024 Ordinary Shares 1.13M $0.00 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.19 based on an exchange rate of $U.S. 1.273980 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F2 Exercisable as to 1,679,325 Ordinary Shares on March 18, 2024 and will be exercisable as to the remainder in monthly installments of 94,704 Ordinary Shares on the last day of each month from April 18, 2024 through February 18, 2027 and 94,899 Ordinary Shares on March 18, 2027.
F3 The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.273980 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F4 Exercisable as to 376,944 Ordinary Shares on June 18, 2024 and will be exercisable as to the remainder in installments of 188,472 Ordinary Shares on January 15, 2025, January 15, 2026, January 15, 2027 and January 15, 2028.
F5 The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable.